Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelis J A Punt

Showing results (1-10 of 281) with videos related to

Pageof 29
Sort By:
Clinical Therapeutics|April 20, 2010
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a reviewJolien Tol, Cornelis J A Punt
Nature Reviews. Clinical Oncology|November 28, 2009
More is less -- combining targeted therapies in metastatic colorectal cancerCornelis J A Punt, Jolien Tol
Discovery Medicine|April 29, 2010
Current issues in the targeted therapy of advanced colorectal cancerNikki Knijn, Jolien Tol, Cornelis J A Punt
American Journal of Clinical Dermatology|July 17, 2003
Does adjuvant systemic therapy with interferon-alpha for stage II-III melanoma prolong survival?Alexander M M Eggermont, Cornelis J A Punt
Nature Reviews. Clinical Oncology|December 7, 2016
From tumour heterogeneity to advances in precision treatment of colorectal cancerCornelis J A Punt, Miriam Koopman, Louis Vermeulen
European Journal of Gastroenterology & Hepatology|June 16, 2004
Systemic treatment of advanced colorectal carcinomaHanneke W M van Laarhoven, Cornelis J A Punt
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Systemic treatment: maintenance compared with holidayCornelis J A Punt, Lieke H J Simkens, Miriam Koopman
Clinical Colorectal Cancer|March 28, 2022
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal CancerCornelis J A Punt, Johannes J M Kwakman, Linda Mol, et al.
Current Opinion in Oncology|May 21, 2014
Optimal duration of systemic treatment in metastatic colorectal cancerLieke H J Simkens, Miriam Koopman, Cornelis J A Punt
Expert Opinion on Pharmacotherapy|June 15, 2007
A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancerMarieke Krol, Miriam Koopman, Carin Uyl-de Groot, et al.
Pageof 29

Showing results (1-10 of 281) with videos related to

Sort By:
Pageof 29
Clinical Therapeutics|April 20, 2010
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a reviewJolien Tol, Cornelis J A Punt
Nature Reviews. Clinical Oncology|November 28, 2009
More is less -- combining targeted therapies in metastatic colorectal cancerCornelis J A Punt, Jolien Tol
Discovery Medicine|April 29, 2010
Current issues in the targeted therapy of advanced colorectal cancerNikki Knijn, Jolien Tol, Cornelis J A Punt
American Journal of Clinical Dermatology|July 17, 2003
Does adjuvant systemic therapy with interferon-alpha for stage II-III melanoma prolong survival?Alexander M M Eggermont, Cornelis J A Punt
Nature Reviews. Clinical Oncology|December 7, 2016
From tumour heterogeneity to advances in precision treatment of colorectal cancerCornelis J A Punt, Miriam Koopman, Louis Vermeulen
European Journal of Gastroenterology & Hepatology|June 16, 2004
Systemic treatment of advanced colorectal carcinomaHanneke W M van Laarhoven, Cornelis J A Punt
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Systemic treatment: maintenance compared with holidayCornelis J A Punt, Lieke H J Simkens, Miriam Koopman
Clinical Colorectal Cancer|March 28, 2022
Long-Term Safety Data on S-1 Administered After Previous Intolerance to Capecitabine-Containing Systemic Treatment for Metastatic Colorectal CancerCornelis J A Punt, Johannes J M Kwakman, Linda Mol, et al.
Current Opinion in Oncology|May 21, 2014
Optimal duration of systemic treatment in metastatic colorectal cancerLieke H J Simkens, Miriam Koopman, Cornelis J A Punt
Expert Opinion on Pharmacotherapy|June 15, 2007
A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancerMarieke Krol, Miriam Koopman, Carin Uyl-de Groot, et al.
Pageof 29